Cervical cancer screening recommendations: now and for the future
M Rayner, A Welp, MH Stoler, LA Cantrell - Healthcare, 2023 - mdpi.com
Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases
annually and approximately 350,000 cancer-related deaths per year. The disease burden is …
annually and approximately 350,000 cancer-related deaths per year. The disease burden is …
Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
AT Ramírez, J Valls, A Baena, FD Rojas… - The Lancet Regional …, 2023 - thelancet.com
Background Cervical cytology remains widely used as the initial tool in cervical cancer
screening worldwide. WHO guidelines recommend replacing cytology with primary HPV …
screening worldwide. WHO guidelines recommend replacing cytology with primary HPV …
Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches
PW Rasmussen, RM Hoffman, S Phiri… - BMC health services …, 2024 - Springer
Background Recently-updated global guidelines for cervical cancer screening incorporated
new technologies—most significantly, the inclusion of HPV DNA detection as a primary …
new technologies—most significantly, the inclusion of HPV DNA detection as a primary …
Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico
JL Castrillo-Diez, C Rivera-Santiago, SM Ávila-Flores… - Viruses, 2024 - mdpi.com
We have been encouraging practicing gynecologists to adopt molecular diagnostics tests,
PCR, and cancer biomarkers, as alternatives enabled by these platforms, to traditional …
PCR, and cancer biomarkers, as alternatives enabled by these platforms, to traditional …
Implementation efforts to support transition to HPV-based cervical cancer screening
M Almonte, M de la Luz Hernández… - The Lancet Public …, 2024 - thelancet.com
On average, it takes 15 years from the landmark publication on a cancer control evidence-
based intervention to achieve 50% uptake in routine practice. 1 In fact, nearly 20 years have …
based intervention to achieve 50% uptake in routine practice. 1 In fact, nearly 20 years have …
Findings and Challenges Replacing the Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in the Private Gynecological Practice in Mexico
HA Barrera-Saldaña, JL Castrillo, CR Santiago… - 2024 - preprints.org
We have been encouraging practicing gynecologists to adopt molecular diagnostics tests,
PCR, and cancer biomarkers, as an alternative enabled by these platforms to traditional …
PCR, and cancer biomarkers, as an alternative enabled by these platforms to traditional …
Cervical Cancer: Pathology, Clinical Records, and Nursing Contributions
SSM Alshahri, AT Alanazi, KMH Kilabi, FK Almutairi… - International journal of … - neliti.com
Background: Cervical cancer is a leading cause of cancer-related deaths among women
worldwide, with over 600,000 new cases and 350,000 deaths annually. The disease …
worldwide, with over 600,000 new cases and 350,000 deaths annually. The disease …